Genetic Study Uncovers Mutation Associated with Fibromuscular Dysplasia

Researchers report first clinically actionable findings for a rare blood vessel disease in a study of four unrelated families, all with the same genetic variant.

1:13 PM

Author | Haley Otman

microscope in lab
Image: Stephanie King

Understanding of fibromuscular dysplasia (FMD), a rare blood vessel disease, is making the jump from the laboratory to the clinic with new findings about a genetic variant.

Researchers found the mutation in a gene that is associated with classical Ehlers-Danlos Syndrome as well, in multifocal FMD. That means it could help clinicians understand whether a person inherited the disease from a relative or another mechanism, in affected families.

"We identified four independent families with the same genetic variant in COL5A1 and vascular disease in a pattern of dysplasia-associated arterial disease, including arterial dissections and multifocal FMD," says senior author Santhi Ganesh, M.D., an associate professor of internal medicine and human genetics, and a cardiologist at the Michigan Medicine Frankel Cardiovascular Center. "Notably, the variant appears to have been inherited from a shared ancestral founder."

Ganesh says the implication of this finding is that other carriers of this variant may exist in the population. The pattern of arterial involvement among carriers of the COL5A1 "G514S" variant is unique, providing clinicians with clues for when to suspect its involvement.

"The identified genetic variant meets clinical criteria for pathogenicity – a first for FMD," she says.

Further, additional variants in the COL5A1 gene were associated with a higher rate of arterial dissections among individuals with multifocal FMD.

Paper cited: "A Novel Recurrent COL5A1 Genetic Variant Is Associated With a Dysplasia-Associated Arterial Disease Exhibiting Dissections and Fibromuscular Dysplasia." Arteriosclerosis, Thrombosis, and Vascular Biology. DOI: 10.1161/ATVBAHA.119.313885


More Articles About:

Lab Notes Cardiovascular: Diseases & Conditions Genetic Disorders Genetics
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Boy in white t-shirt, just chin showing, with hands holding a stethoscope on his chest.
Health Lab

Distance, insurance, social factors may hinder access to lifesaving heart monitoring for children

New research suggests that social, economic and geographic factors may influence whether patients who undergo the Fontan surgery for complex congenital heart disease receive the recommended lifelong cardiac monitoring.
A smartphone displaying a red heart with a white EKG line on its screen, set against a teal background.
Health Lab

Mobile health app improves heart failure medication use, dosing after hospitalization

A U-M-led trial found a mobile app improved use and dosing of recommended heart failure medications during the 90 days following a hospital discharge.
Three people in a bar watch a television displaying a sports logo and a person smiling. Shelves with bottles and a counter with glasses are visible.
Health Lab

Jalen Hurts’ blood clot diagnosis: doctors answer common questions

After Jalen Hurts’ blood clot diagnosis, Michigan Medicine experts explain clot risks, treatment and returning safely to sports.
A pill bottle is open and pills are placed onto a hand
Health Lab

Could a diabetes medication be the next wonder drug?

Researchers identified how sotagliflozin may reduce heart attack and stroke risk, potentially offering benefits beyond diabetes care
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.
Two people in medical scrubs are in a blurred hospital setting. In the foreground, hands are holding a digital tablet.
Health Lab

Digital alerts support timely treatment decisions of critically ill cardiac patients

Well-designed alerts for critically ill cardiac patients can change what happens at the bedside, according to new Michigan Medicine research.